TABLE 2.
Patients who experienced adverse outcomes
| Age at diagnosis |
Sex | Smoking status |
Subsite | T Classification |
N Classification (AJCC 8th ed.) |
N Classification (AJCC 7th ed.) |
ENE | PNI | Overall stage |
ECOG risk class |
Re- resection |
Final margin (mm) |
Event | Time to event (months) |
Salvage therapy |
Disease status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61 | Male | Never | Base of tongue | T1 | N1 | N2a | N0 | No | I | Low | No | Negative | Local recurrence | 18 | Surgery | NED |
| 59 | Female | Current | Tonsil | T1 | N0 | N0 | N/A | No | I | Low | Yes | 4–4.9 | Local recurrence | 17 | Radiation | NED |
| 53 | Male | Never | Base of tongue | T1 | N1 | N2a | N0 | No | I | Intermediate | No | Close | Regional recurrence | 27 | Surgery | NED |
| 60 | Male | Current | Base of tongue | T1 | N2 | N2b | Yes | Yes | II | High | Yes | Negative | Regional recurrence | 7 | Chemoradiation | NED |
| 57 | Male | Never | Tonsil | T1 | N1 | N1 | N0 | No | I | Low | No | >5 | Regional recurrence | 24 | Chemoradiation | NED |
| 54 | Male | Former | Base of tongue | T1 | N1 | N1 | N0 | No | I | Low | No | >5 | Distant metastasis | 27 | Chemotherapy | Active disease |
| 69 | Male | Never | Base of tongue | T1 | N0 | N0 | N/A | No | I | Intermediate | Yes | 1–1.9 | Distant metastasis | 41 | Chemotherapy | Active disease |
| 74 | Male | Former | Tonsil | T2 | N0 | N0 | N/A | No | I | Intermediate | No | 1–1.9 | Distant metastasis, death | 12 | Chemoradiation | Deceased |
| 88 | Male | Unknown | Base of tongue | T2 | N2 | N2b | No | No | II | High | No | Close | Death | 8 | N/A | Deceased |
| 88 | Male | Current | Base of tongue | T1 | N1 | N2a | No | Unknown | I | Intermediate | No | Close | Death | 28 | N/A | Deceased |
| 63 | Male | Former | Tonsil | T1 | N1 | N2b | Yes | No | I | High | No | 2–2.9 | Death | 6 | N/A | Deceased |
Abbreviations: AJCC, American Joint Committee on Cancer; ECOG, Eastern Cooperative Oncology Group; ENE, extranodal extension; PNI, perineural invasion.